Relsys International Announces Power Reports Product Selected by Top Pharmaceutical Companies

Relsys International, the leading developer of adverse event reporting software, has announced that its new Power Reports product has been chosen by two of the world's largest pharmaceutical companies as part of their drug safety and risk management programs. The software, launched at the Annual Meeting of the Drug Information Association, provides multi-dimensional analysis of pharmaceutical safety data to create reports, enabling users to make key business decisions quickly and confidently.

Key Takeaways:

• Power Reports features a highly intuitive user interface that minimizes the need for technical training, allowing users to search for, extract, and transform data into useful reports.
• The product allows users to query and analyze data from multiple angles, develop simple or complex reports, and easily share critical knowledge across the enterprise using popular software applications such as Microsoft Excel or Adobe Acrobat.
• Power Reports meets a number of important customer needs, including saving companies enormous amounts of time due to its ease of use and potential to help companies comply with regulatory requirements.
• The product is optimized to work within the Argus software suite, built using industry-standard reporting tools, and is available for immediate purchase.
• Power Reports has been selected by two of the world's largest pharmaceutical companies, demonstrating its value to the pharmaceutical industry.
• Relsys International provides comprehensive adverse event and complaint tracking software and services that help pharmaceutical, biotech, and medical device companies ensure ongoing compliance to global regulations.

Statistics:

• Power Reports allows users to query and analyze data from multiple angles, enabling them to develop simple or complex reports.
• The product minimizes the need for technical training, allowing users to easily extract and transform data into useful reports.
• Power Reports is optimized to work within the Argus software suite, built using industry-standard reporting tools.
• Relsys International provides adverse event and complaint tracking software and services to the pharmaceutical, biotech, and medical device industries.

Sources:

• Relsys International, Press Release, "Relsys International Announces Power Reports Product Selected by Top Pharmaceutical Companies"
• PRNewswire, "Relsys International Announces Power Reports Product Selected by Top Pharmaceutical Companies"
• http://www.relsys.net/